Mental health economics, health service provision, and the practice of geriatric psychiatry

Current Opinion in Psychiatry

Volumn 21, Issue 6, 2008, Pages 546-550

  Suh, Guk Hee ^a,c   Han, Changsu ^b  

^a Hallym University   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Hallym University Medical Center   (South Korea)

Author keywords

Cost effectiveness; Geriatric psychiatry; Health economics; Mental health; Service

Indexed keywords

CHOLINESTERASE INHIBITOR;

ALZHEIMER DISEASE; BUDGET; COST EFFECTIVENESS ANALYSIS; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DISEASE SEVERITY; ECONOMIC EVALUATION; GERONTOPSYCHIATRY; GOVERNMENT; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH ECONOMICS; HUMAN; LIFE EXPECTANCY; MENTAL HEALTH CARE; OUTCOMES RESEARCH; QUALITY OF LIFE; RESOURCE ALLOCATION; REVIEW; SOCIAL WELFARE;

COST-BENEFIT ANALYSIS; GERIATRIC PSYCHIATRY; GOVERNMENT; HEALTH POLICY; HEALTH SERVICES FOR THE AGED; HUMANS; MENTAL HEALTH SERVICES; PHYSICIAN'S PRACTICE PATTERNS; UNITED STATES;

EID: 56249108788     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/YCO.0b013e32830f1bd5     Document Type: Review

References (39)

1. Suh GH. Health economics: basic principles and application in mental health. Int Psychogeriatr 2007; 19:993-1002. This editorial provides important basic knowledge of health economics in view of mental health. It highlights all stages of a typical economic evaluation with useful examples.
2. Knapp M. Economic outcomes and levers: impacts for individuals and society. Int Psychogeriatr 2007; 19:483-495. This consensus conference paper introduces recent debate in England over the decision by NICE not to recommend the use of antidementia drugs on the grounds of cost-effectiveness. It highlights the levers to bring about change.
3. Wimo A. Clinical and economic outcomes: friends or foe? Int Psychogeriatr 2007; 19:497-507. This consensus conference paper introduces clinical and economic outcomes for dementia. It emphasizes that clinical outcomes must be combined with economic outcomes suitable for cost-effective analysis.
4. Green C. Modelling disease progression in Alzheimer's disease. A review of modelling methods used for cost-effectiveness analysis. Pharmacoeconomics 2007; 25:735-750.
5. Hoch JS, Dewa CS. Lessons from trial-based cost-effectiveness analyses of mental health interventions. Pharmacoeconomics 2007; 25:807-816.
6. Kang IO, Lee SY, Kim SY, et al. Economic cost of dementia patients according to the limitation of the activities of daily living in Korea. Int J Geriatr Psychiatry 2007; 22:675-681.
7. Suh GH, Knapp M, Kang CJ. The economic costs of dementia in Korea, 2002. Int J Geriatr Psychiatry 2006; 21:722-728.
8. Allegri RF, Butman J, Arizaga RL, et al. Economic impact of dementia in developing countries: an evaluation of costs of Alzheimer-type dementia in Argentina. Int Psychogeriatr 2007; 19:705-718.
9. Boström F, Jönsson L, Minthon L, Londos E. Patients with Lewy body dementia use more resources than those with Alzheimer's disease. Int J Geriatr Psychiatry 2007; 22:713-719.
10. Franzini L, Dyer CB. Healthcare costs and utilization of vulnerable elderly people reported to adult protective services for self-neglect. J Am Geriatr Soc 2008; 56:667-676.
11. Beran MS, Laouri M, Suttorp M, et al. Medication costs: the role physicians play with their senior patients. J Am Geriatr Soc 2007; 55:102-107.
12. Rabins PV, Black BS. Measuring quality of life in dementia: purposes, goals, challenges and progress. Int Psychogeriatr 2007; 19:401-407. This consensus conference paper highlights the limitations of current QOL measurements for older people.
13. Nordberg G, Wimo A, Jönsson L, et al. Time use and cost of institutionalized elderly persons with or without dementia: results from the Nordanstig cohort in the Kungsholmen project - a population based study in Sweden. Int J Geriatr Psychiatry 2007; 22:639-648. This study provides information on the amount of caregivers' time necessary according to whether patients have dementia and loss of ADL function, which will be very valuable for economic analysis.
14. Ekman M, Berg J, Wimo A, et al. Health utilities in mild cognitive impairment and dementia: a population study in Sweden. Int J Geriatr Psychiatry 2007; 22:649-655. This is the first study to report health utility weighting of mild cognitive impairment. It will make modeling of the early signs of dementia to death possible, which will be helpful for future projections of cost estimation or cost-effectiveness analysis.
15. Getsios D, Migliaccio-Walle K, Caro JJ. NICE cost-effectiveness appraisal of cholinesterase inhibitors. Pharmacoeconomics 2007; 25:997-1006. This article provides point-by-point critiques on the decision by NICE not to recommend the use of antidementia drugs on the grounds of cost-effectiveness.
16. Suh GH, Jung HY, Lee CU, et al. Economic and clinical benefits of galantamine in the treatment of mild to moderate Alzheimer's disease in a Korean population: a 52-weeek prospective study. J Korean Med Sci 2008; 23:10-17.
17. Nichols LO, Chang C, Lummus A, et al. The cost-effectiveness of a behavior intervention with caregivers of patients with Alzheimer's disease. J Am Geriatr Soc 2008; 56:413-420.
18. Bouman A, van Rossum E, Ambergen T, et al. Effects of a home visiting program for older people with poor health status: a randomized, clinical trial in the Netherlands. J Am Geriatr Soc 2008; 56:397-404. This article highlights that a home visiting program for older people with poor health status was neither effective nor cost-effective.
19. Donohue JM, Pincus HA. Reducing the societal burden of depression. Pharmacoeconomics 2007; 25:7-24.
20. Mason A, Weatherly H, Spilsbury K, et al. The effectiveness and cost-effectiveness of respite for caregivers of frail older people. J Am Geriatr Soc 2007; 55:290-299. This article highlights that respite for caregivers of frail older people is neither effective nor cost-effective. Respite does not change patient's outcomes at all.
21. Galor O, Zeira J. Income distribution and macroeconomics. Rev Econ Stud 1993; 60:35-52.
22. Ferri CP, Prince M, Brayne C, et al. Global prevalence of dementia: a Delphi consensus study. Lancet 2005; 366:2112-2117.
23. Murray CJL, Lopez AD. The global burden of disease. A comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. In: Murray CJL, Lopez AD, editors. Cambridge, MA: Harvard School of Public Health, Harvard University Press; 1996.
24. Prince M, Livingston G, Katona C. Mental healthcare for the elderly in low-income countries: a health systems approach. World Psychiatry 2007; 6:5-13. This study discussed the health systems and the attitudes toward geriatric mental health services in developed and developing countries. The authors suggested that the most cost-effective way of treating dementia will be through supporting family caregivers. Also, they place importance on an awareness program for improving mental health services.
25. Patel V. Health systems research: a pragmatic method of meeting mental health needs in low income countries. In: Andrews G, Henderson S, editors. Unmet need in psychiatry. Cambridge: Cambridge University Press; 2003. pp. 353-377.
26. Banerjee S, Chan J. Organization of old age psychiatric services. Psychiatry 2005; 4:73-76.
27. Han C, Lee JY, Lee DW, et al. Development of hybrid model for integrating management of geriatric depression and dementia in urban area. J Korean Geriatr Soc 2006; 10:104-114.
28. Draper B, Brodaty H, Low LF. A tiered model of psychogeriatric service delivery: an evidence-based approach. Int J Geriatr Psychiatry 2006; 21:645-653.
29. Jung HG, Ahn JS, Park MH, et al. Survey of public health service needs of live-alone elderly in urban area. J Korean Geriatr Psychiatry 2006; 10:80-83.
30. Tout K. Ageing in developing countries. Oxford: Oxford University Press; 1989.
31. Prince M. Care arrangements for people with dementia in developing countries. Int J Geriatr Psychiatry 2004; 19:170-177.
32. Streim JE. Unique tools of the trade. Nursing homes and research in geriatric psychiatry. Am J Geriatr Psychiatry 2005; 13:437-440.
33. Snowdon J. Psychogeriatric services in the community and in long-term care facilities: needs and developments. Curr Opin Psychiatry 2007; 20:533-538. This paper reviewed community mental health services for the geriatric population. The care systems of long-term facilities and nursing homes were reviewed. The author recommends that a culture and social-specific health delivery system for the increasing number of elderly patients should be prepared.
34. Calkins MP. Assisted living, nursing homes, and dementia care settings: exploring distinctions and commonalities. Gerontologist 2007; 47:263-267.
35. Bartels SJ, Moak GS, Dums AR. Models of mental health services in nursing homes: a review of the literature. Psychiatr Serv 2002; 53:1390-1396.
36. Bartels SJ. Quality, costs, and effectiveness of services for older adults with mental disorders: a selective overview of recent advances in geriatric mental health services research. Curr Opin Psychiatry 2002; 15:411-416.
37. Wolfs CA, Verhey FR, Kessels A, et al. GP concordance with advice for treatment following a multidisciplinary psychogeriatric assessment. Int J Geriatr Psychiatry 2007; 22:233-240.
38. Bellantonio S, Kenny AM, Fortinsky RH, et al. Efficacy of a geriatrics team intervention for residents in dementia-specific assisted living facilities: effect on unanticipated transitions. J Am Geriatr Soc 2008; 56:523-528.
39. Nishita CM, Wilber KH, Matsukoto S, et al. Transitioning residents from nursing facilities to community living: who wants to leave? J Am Geriatr Soc 2008; 56:1-7.